Newsbenzinga
CVS Health Raises FY2026 Adj EPS Guidance from $7.30-$7.50 to $7.90-$8.10 vs $7.45 Est; FY2026 Revenue expected to be more than $414.000M vs $409.235B Est
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…